Skip to main content
Screener/Healthcare/Biotechnology

LRMR — Larimar Therapeutics, Inc.

NASDAQ
$4.08 (—)
Small CapPenny StockUnder $5Healthcare
$2.71
$6.42
—
—
EPS (TTM)$-2.10
P/E Ratio-2.26
Dividend Yield—
Market Cap$316.6M
Volume—
Prev Close$3.93
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$29.6M$-0.35——
Q4 '25$0-$62.5M$-0.73——
Q3 '25$0-$47.7M$-0.61——
Q2 '25$0-$26.2M$-0.41——
Q1 '25$0-$29.3M$-0.46——
Q4 '24$0-$28.8M$-0.45——
Q3 '24$0-$15.5M$-0.24——
Q2 '24$0-$21.6M$-0.34——
Get Your Daily Market Recap